ANVISA-2020-0045-V045
Type IB variation for application ANVISA-2020-0045. Type IB variation: Analytical Method Change for Haemoferrin — major revision
Variation Number
ANVISA-2020-0045-V045
Type
Type IB
Application
Change
Status
Pending
Fee
€1,531
Submitted
2023-02-12
Approved
—
Description
Type IB variation: Analytical Method Change for Haemoferrin — major revision